↓ Skip to main content

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention

Overview of attention for article published in Stem Cell Research & Therapy, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
Published in
Stem Cell Research & Therapy, March 2022
DOI 10.1186/s13287-022-02787-2
Pubmed ID
Authors

Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, Camille Carmona, Yang Zhou, Derek Lee, Jiaji Yu, Jie Huang, Jocelyn T. Kim, Vaithilingaraja Arumugaswami, Pin Wang, Lili Yang

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 12%
Student > Bachelor 3 9%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Professor > Associate Professor 2 6%
Other 4 12%
Unknown 15 45%
Readers by discipline Count As %
Nursing and Health Professions 4 12%
Immunology and Microbiology 4 12%
Biochemistry, Genetics and Molecular Biology 2 6%
Computer Science 2 6%
Engineering 2 6%
Other 6 18%
Unknown 13 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#13,118,605
of 23,460,553 outputs
Outputs from Stem Cell Research & Therapy
#879
of 2,469 outputs
Outputs of similar age
#169,210
of 440,938 outputs
Outputs of similar age from Stem Cell Research & Therapy
#20
of 83 outputs
Altmetric has tracked 23,460,553 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,469 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.